pocketful logo light
pocketful logo light
Dr Lal Pathlabs Ltd logo

Dr Lal Pathlabs Ltd

NSE: LALPATHLAB BSE: 539524

1905.20

(1.41%)

Thu, 06 Aug 2026, 11:20 am

Dr Lal Pathlabs Share Price Live Chart

1 Day

(1.41%)

No Result Found

Summary

  • Market Cap (in Cr)

    26817.85

  • Net Profit (in Cr)

    492.25

  • P/B

    9.53

  • Sector P/E

    58.57

  • P/E

    42.52

  • EV/EBITDA

    25.39

  • Debt/Equity (Industry)

    0.18

  • Interest Cover (Industry)

    12.19

  • ROCE (Industry)

    17.69

  • RONW (Industry)

    14.86

  • ROE

    24.48

  • ROCE

    29.22

  • Debt/Equity

    0.10

  • EPS (TTM)

    31.48

  • Dividend Yield

    1.53

  • Book Value

    149.62

  • Interest Cover

    29.01

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters53.2153.2253.2253.7953.91
FII17.1820.2921.8621.6823.91
DII21.3819.2118.4917.9116.08
Public8.227.286.446.626.10
Government0.010.01000

Read More

Technical Analysis

RSI

73.90

MACD

66.49

50 DMA

1689.61

200 DMA

1520.39

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2431.102121.402013.301811.701703.601502.001192.30
Fibonacci2121.402003.091930.011811.701693.391620.311502.00
Camarilla1990.371961.981933.591811.701876.811848.421820.03

Pivots Level: Classic

R3

+619.40

2431.10

R2

+309.70

2121.40

R1

+201.60

2013.30

1811.70
1811.70
Pivot Point
LTP: 1928

S1

-108.10

1703.60

S2

-309.70

1502.00

S3

-619.40

1192.30

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1861.58

  • 20-EMA

    1806.50

  • 30-EMA

    1768.05

  • 50-EMA

    1711.73

  • 100-EMA

    1627.87

  • 200-EMA

    1561.89

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
30 Apr 2026board-meetingsAccounts, Quarterly Results
30 Apr 2026dividend₹4.00 Dividend /Share26 Jun 2026
30 Apr 2026agm
30 Jan 2026board-meetingsQuarterly Results
30 Jan 2026dividend₹3.50 Dividend /Share05 Feb 2026
05 Jan 2026dividendInterim Dividend - Rs. - 3.505 Feb 2026
12 Dec 2025bonus1:1 Bonus Issue of Equity Shares12 Dec 2025
19 Nov 2025bonusBonus issue 1:119 Dec 2025
31 Oct 2025board-meetingsQuarterly Results, Half Yearly Results, Interim Dividend, Bonus Issue
31 Oct 2025dividend₹7.00 Dividend /Share07 Nov 2025

Read More

Peer Comparison

Dr Lal Pathlabs Ltd logo

Dr Lal Pathlabs Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Read More

Dr Lal Pathlabs Ltd About

Dr. Lal PathLabs is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations.

Industry

Healthcare

Founded

1995

Headquarters

CEO

Arvind Lal

Employees

Contact

Website icon

Website

http://www.lalpathlabs.com

Email icon

Email

cs@lalpathlabs.com

Phone icon

Phone

91-011-3024 4149

Location icon

Location

E-2 Block Sector 18, Rohini, New Delhi, New Delhi, 110085

Read More

Dr Lal Pathlabs Ltd Company History

YearHistory
2017
  • Dr Lal PathLabs is Amalgameted with Ria and Pathology Private Limited
2018
  • Amalgamation of Shree Computerised Pathology Laboratory, Modern Diagnostics & Modern Lab
2021
  • Dr Lal PathLabs Launches Bangalore Reference Laboratory.
2023
  • NCLT has given approval for Amalgamation between Dr. Lal PathLabs Limited and APL Institute of Clinical Laboratory & Research Private Limited.
2024
  • NCLT, Allahabad Bench sanctioned the Scheme of Amalgamation between two Subsidiary Companies of Dr. Lal PathLabs Limited.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GOLDMAN SACHS BANK EUROPE SE - ODIblockBuy33414316020 Oct 2025
GOLDMAN SACHS (SINGAPORE) PTE - ODIblockSell33414316020 Oct 2025
MULTI-MANAGER ICVCbulkSell4349432997.1106 Jan 2025
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy129492550.925 Oct 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy693192550.925 Oct 2022
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell693192550.925 Oct 2022
ISHARES INDIA SC MAURITIUS COMPANYblockSell129492550.925 Oct 2022
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell692502377.517 Oct 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy692502377.517 Oct 2022
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy129342377.517 Oct 2022

Read More

Dr Lal Pathlabs Ltd News

Dr Lal PathLabs Q1 Results: Revenue Growth Guidance Raised to Mid-Teens

Dr Lal PathLabs raises FY revenue growth outlook to mid-teens after a strong Q1, plans 12-15 new labs, and estimates capex of INR 140-150 crore for M&A and radiology expansion.

27 Jul 2026

companies

Dr Lal Pathlabs Director Gurinder Singh Kalra Steps Down

Gurinder Singh Kalra ceases to be an independent director of Dr. Lal PathLabs Limited on July 26, 2026, following the completion of his tenure, the company disclosed to stock exchanges.

26 Jul 2026

companies

Dr Lal Pathlabs declares ₹4 dividend at AGM

Dr Lal Pathlabs Limited concluded its 32nd AGM on July 25, 2026, declaring a final dividend of ₹4 per share for FY26. Shareholders also approved key board appointments and remuneration revisions.

25 Jul 2026

companies

Dr. Lal PathLabs Q1 Revenue Rises to 8B Rupees

Dr. Lal PathLabs reports Q1 revenue of 8B rupees vs 6.7B YoY, net profit at 1.7B rupees vs 1.3B YoY, EBITDA margin expands to 31% vs 28.7% YoY.

24 Jul 2026

companies

Dr Lal Pathlabs wins ESOP tax appeal

Income Tax appellate order allows appeal on ESOP expenses of ₹32.66 crore, decided in company's favour.

17 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Dr Lal Pathlabs Ltd?

    As of 06/08/2026 at 4:50 PM, Dr Lal Pathlabs Ltd shares are trading at 1905.20.

  • 2.What is the market cap. of Dr Lal Pathlabs Ltd?

    As of 06/08/2026, the market capitalization of Dr Lal Pathlabs Ltd is 31,976.90 crore.

  • 3.When was Dr Lal Pathlabs Ltd founded?

    Dr Lal Pathlabs Ltd was founded in 1995.

  • 4.What are the P/E and P/B ratios of Dr Lal Pathlabs Ltd?

    As of 06/08/2026, Dr Lal Pathlabs Ltd has a P/E ratio of 58.81 and a P/B ratio of 9.53.

  • 5.How can I buy shares of Dr Lal Pathlabs Ltd?

    You can buy shares of Dr Lal Pathlabs Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Dr Lal Pathlabs Ltd?

    As of March,2026, promoters hold 53.21% in Dr Lal Pathlabs Ltd, while FIIs, DIIs and public shareholders hold 17.18%, 21.38% and 8.22%, respectively. The government holds 0.01%.

  • 7.Does Dr Lal Pathlabs Ltd pay dividends?

    Yes, Dr Lal Pathlabs Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹4.00 Dividend /Share per share.

  • 8.What is the dividend yield of Dr Lal Pathlabs Ltd?

    As of 06 August, 2026, the dividend yield of Dr Lal Pathlabs Ltd stands at 0.84%.

  • 9.What are the latest financial results of Dr Lal Pathlabs Ltd?

    For January,2024, Dr Lal Pathlabs Ltd reported revenue of 2,461.00 crore and a net profit of 487.00 crore.

  • 10.What is the Stock symbol of Dr Lal Pathlabs Ltd?

    LALPATHLAB is the stock symbol of Dr Lal Pathlabs Ltd.

  • 11.Who is the CEO of Dr Lal Pathlabs Ltd?

    The CEO of Dr Lal Pathlabs Ltd is Arvind Lal.

Open Your Free Demat Account

Enter your phone number